Stronger correlation of Bcl-3 than Bcl-2, Bcl-xL, costimulation, or antioxidants with adjuvant-induced T cell survival

Annals of the New York Academy of Sciences

Volumn 975, Issue , 2002, Pages 114-131

  Mitchell, Thomas C ^a,i   Teague, T Kent ^b   Hildeman, David A ^c   Bender, Jeremy ^d   Rees, William A ^e   Kedl, Ross M ^f   Swanson, Brad ^g   Kappler, John W ^g,h   Marrack, Philippa ^g,h,i  

^a University of Louisville School of Medicine   (United States)

^b University of Oklahoma Tulsa College of Medicine   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^d Ancora Pharmaceuticals   (United States)

^e GLAXOSMITHKLINE   (United States)

^f 3M COMPANY   (United States)

^g HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^h UNIVERSITY OF COLORADO   (United States)

ⁱ Baxter Building ^*  (United States)

Author keywords

Adjuvants; Bcl 2; Bcl 3; Bcl xL; T cell survival

Indexed keywords

ANTIOXIDANT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 7; PROTEIN BCL 2; PROTEIN BCL 3; PROTEIN BCL XL; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; CELL DIVISION; CELL FUNCTION; CELL PROLIFERATION; CELL SURVIVAL; CLONAL ANERGY; CONFERENCE PAPER; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; FLOW CYTOMETRY; IMMUNE RESPONSE; IMMUNOSTIMULATION; NONHUMAN; OXIDATIVE STRESS; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 0036962440     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2002.tb05946.x     Document Type: Conference Paper

References (51)

1. + T cells in mice tolerant to Staphylococcus aureus enterotoxin B. Nature 349: 245-248.
2. WEBB, S., C. MORRIS & J. SPRENT. 1990. Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell 63: 1249-1256.
3. KAPPLER, J.W., N. ROEHM & P. MARRACK. 1987. T cell tolerance by clonal elimination in the thymus. Cell 49: 273-280.
4. AOKI, Y., K. HIROMATSU, J. USAMI, et al. 1994. Clonal expansion but lack of subsequent clonal deletion of bacterial superantigen-reactive T cells in murine retroviral infection. J. Immunol. 153: 3611-3621.
5. CHILLER, J.M. & W.O.WEIGLE. 1973. Termination of tolerance to human gamma globulin in mice by antigen and bacterial lipopolysaccharide (endotoxin). J. Exp. Med. 137: 740-750.
6. + T cells to cause immunopathology. J. Exp. Med. 187: 763-774.
7. KEARNEY, E.R., K.A. PAPE, D.Y. LOH & M.K. JENKINS. 1994. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1: 327-339.
8. MITCHELL, T., J. KAPPLER & P. MARRACK. 1999. Bystander virus infection prolongs activated T cell survival. J. Immunol. 162: 4527-4535.
9. OHASHI, P.S., S. OEHEN, K. BUERKI, et al. 1991. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65: 305-317.
10. OLDSTONE, M.B., M. NERENBERG, P. SOUTHERN, et al. 1991. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 65: 319-331.
11. ROCKEN, M., J.F. URBAN & E.M. SHEVACH. 1992. Infection breaks T-cell tolerance. Nature 359: 79-82.
12. VELLA, A.T., J.E. MCCORMACK, P.S. LINSLEY, et al. 1995. Lipopolysaccharide interferes with the induction of peripheral T cell death. Immunity 2: 261-270.
13. MITCHELL, T.C., D. HILDEMAN, R.M. KEDL, et al. 2001. Immunological adjuvants promote activated T cell survival via induction of Bcl-3. Nat. Immunol. 2: 397-402.
14. POLTORAK, A., I. SMIRNOVA, X. HE, et al. 1998. Genetic and physical mapping of the Lps locus: identification of the toll-4 receptor as a candidate gene in the critical region. Blood Cells Mol. Dis. 24: 340-355.
15. MUELLER, D.L., M.K. JENKINS & R.H. SCHWARTZ. 1989. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol. 7: 445-480.
16. + T cell tolerance induction versus priming is independent of the rate and number of cell divisions. J. Immunol. 164: 649-655.
17. + T cells in transgenic mice expressing H-2Kb in the liver. Eur. J. Immunol. 25: 1932-1942.
18. + T cells. Int. Immunol. 4: 599-610.
19. JONES, L.A., L.T. CHIN, D.L. LONGO & A.M. KRUISBEEK. 1990. Peripheral clonal elimination of functional T cells. Science 250: 1726-1729.
20. MCCORMACK, J.E., J.E. CALLAHAN, J. KAPPLER & P.C.MARRACK. 1993. Profound deletion of mature T cells in vivo by chronic exposure to exogenous superantigen. J. Immunol. 150: 3785-3792.
21. ROCHA, B. & H.VON BOEHMER. 1991. Peripheral selection of the T cell repertoire. Science 251: 1225-1228.
22. ZHANG, L.I., D.R. MARTIN, W.P. FUNG-LEUNG, et al. 1992. Peripheral deletion of mature CD8+ antigen-specific T cells after in vivo exposure to male antigen. J. Immunol. 148: 3740-3745.
23. KHORUTS, A., A. MONDINO, K.A. PAPE, et al. 1998. A natural immunological adjuvant enhances T cell clonal expansion through a CD28-dependent, interleukin (IL)-2-independent mechanism. J. Exp. Med. 187: 225-236.
24. VELLA, A.T., T. MITCHELL, B.GROTH, et al. 1997. CD28 engagement and proinflammatory cytokines contribute to T cell expansion and long-term survival in vivo. J. Immunol. 158: 4714-4720.
25. MAXWELL, J.R., C. RUBY, N.I. KERKVLIET & A.T. VELLA. 2002. Contrasting the roles of costimulation and the natural adjuvant lipopolysaccharide during the induction of T cell immunity. J. Immunol. 168: 4372-4381.
26. BOISE, L.H., M. GONZALEZ-GARCIA, C.E. POSTEMA, et al. 1993. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74: 597-608.
27. BOISE, L.H., A.J. MINN, P.J. NOEL, et al. 1995. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity 3: 87-98.
28. AKBAR, A.N., N.J. BORTHWICK, R.G. WICKREMASINGHE, et al. 1996. Interleukin-2 receptor common gamma-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax, bcl-xS) gene expression. Eur. J. Immunol. 26: 294-299.
29. VELLA, A.T., S. DOW, T.A. POTTER, et al. 1998. Cytokine-induced survival of activated T cells in vitro and in vivo. Proc. Natl. Acad. Sci. USA 95: 3810-3815.
30. WHITE, J., A. HERMAN, A.M. PULLEN, et al. 1989. The V beta-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell 56: 27-35.
31. LYONS, A.B. & C.R.PARISH. 1994. Determination of lymphocyte division by flow cytometry. J. Immunol. Methods 171: 131-137.
32. HEATH, A.W., W.W. WU & M.C.HOWARD. 1994. Monoclonal antibodies to murine CD40 define two distinct functional epitopes. Eur. J. Immunol. 24: 1828-1834.
33. MAXWELL, J.R., J.D. CAMPBELL, C.H. KIM & A.T.VELLA. 1999. CD40 activation boosts T cell immunity in vivo by enhancing T cell clonal expansion and delaying peripheral T cell deletion. J. Immunol. 162: 2024-2034.
34. VAN KOOTEN, C. & J. BANCHEREAU. 2000. CD40-CD40 ligand. J. Leukocyte Biol. 67: 2-17.
35. HILDEMAN, D.A., T. MITCHELL, T.K. TEAGUE, et al. 1999. Reactive oxygen species regulate activation-induced T cell apoptosis. Immunity 10: 735-744.
36. CAMPBELL, J.D., M. COLE, B. BUNDITRUTAVORN & A.T.VELLA. 1999. Ascorbic acid is a potent inhibitor of various forms of T cell apoptosis. Cell. Immunol. 194: 1-5.
37. HILDEMAN, D.A., B. WHITLOCK, S. GARDAI, et al. 2002. Intracellular expression of free radical scavengers protects activated T cells from death. In preparation.
38. OHNO, H., G. TAKIMOTO & T.W. MCKEITHAN. 1990. The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control. Cell 60: 991-997.
39. KERR, L.D., C.S. DUCKETT, P. WAMSLEY, et al. 1992. The proto-oncogene bcl-3 encodes an I kappa B protein. Genes Dev. 6: 2352-2363.
40. NOLAN, G.P., T. FUJITA, K. BHATIA, et al. 1993. The bcl-3 proto-oncogene encodes a nuclear I kappa B-like molecule that preferentially interacts with NF-kappa B p50 and p52 in a phosphorylation-dependent manner. Mol. Cell. Biol. 13: 3557-3566.
41. BOURS, V., G. FRANZOSO, V. AZARENKO, et al. 1993. The oncoprotein Bcl-3 directly transactivates through kappa B motifs via association with DNA-binding p50B homodimers. Cell 72: 729-739.
42. FRANZOSO, G., V. BOURS, S. PARK, et al. 1992. The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-kappa B-mediated inhibition. Nature 359: 339-342.
43. FUJITA, T., G.P. NOLAN, H.C. LIOU, et al. 1993. The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers. Genes Dev. 7: 1354-1363.
44. GRUMONT, R.J. & S. GERONDAKIS. 1994. Alternative splicing of RNA transcripts encoded by the murine p105 NF-kappa B gene generates I kappa B gamma isoforms with different inhibitory activities. Proc. Natl. Acad. Sci. USA 91: 4367-4371.
45. GRUMONT, R.J., J. FECONDO & S. GERONDAKIS. 1994. Alternate RNA splicing of murine nfkb1 generates a nuclear isoform of the p50 precursor NF-kappa B1 that can function as a transactivator of NF-kappa B-regulated transcription. Mol. Cell. Biol. 14: 8460-8470.
46. GILMORE, T.D. 1999. The Re1/NF-kappaB signal transduction pathway: introduction. Oncogene 18: 6842-6844.
47. REBOLLO, A., L. DUMOUTIER, J.C. RENAULD, et al. 2000. Bcl-3 expression promotes cell survival following interleukin-4 deprivation and is controlled by AP1 and AP1-like transcription factors. Mol. Cell. Biol. 20: 3407-3416.
48. SCHWARZ, E.M., P. KRIMPENFORT, A. BERNS & I.M. VERMA. 1997. Immunological defects in mice with a targeted disruption in Bcl-3. Genes Dev. 11: 187-197.
49. FRANZOSO, G., L. CARLSON, T. SCHARTON-KERSTEN, et al. 1997. Critical roles for the Bcl-3 oncoprotein in T cell-mediated immunity, splenic microarchitecture, and germinal center reactions. Immunity 6: 479-490.
50. VELLA, A.T., M.T. SCHERER, L. SCHULTZ, et al. 1996. B cells are not essential for peripheral T-cell tolerance. Proc. Natl. Acad. Sci. USA 93: 951-955.
51. HU, H., G. HUSTON, D. DUSO, et al. 2001. CD4(+) T cell effectors can become memory cells with high efficiency and without further division. Nat. Immunol. 2: 705-710.